Millipore Expands BioPharma CRO Services in Europe
Millipore Corporation has moved its European BioPharma services unit to new, expanded facilities to accommodate strong growth in the biotechnology sector. The new facilities are located in Milton Park, near Didcot in Oxfordshire, England.
Millipore’s BioPharma Services unit is the first global contract research organization (CRO) dedicated exclusively to large molecule bioanalytical work. The unit arose from Millipore’s acquisition in August, 2009 of BioAnaLab, which specializes in the analysis of biopharmaceuticals and has been supporting drug development for the pharmaceutical industry for the past several years.
Geoff Hale, Managing Director of BioAnaLab said: “The new laboratory provides us with space to continue our growth as we expand the range of services we provide.” Craig Morley, Global Managing Director of Millipore’s BioPharma Services added: “"The new facility complements the outstanding facilities at our St. Charles site and is a significant milestone in our development as "The World's Large Molecule Lab."
Most read news
Organizations
Other news from the department manufacturing

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Key factor in mitochondrial calcium uptake and bioenergetics identified
Frost & Sullivan: BRIC is not delivering promises of high growth in healthcare markets - The dialogue evolves as it’s no longer about volume, cost and size
QIAGEN Acquires Biosystems Business from Biotage - Transaction adds fundamental assay technology for high-resolution sequence detection and quantification of genetic variations
2,6-Di-tert-butylphenol

Accessing DNA in the cell's powerhouse to treat disease
Seeing the colored light - Bee brains open way for better cameras

Triastek announces research collaboration with Lilly - Application of 3D printing technology in oral delivery of drugs
US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE Smallpox Vaccine
Ablynx Announces Positive Phase I Results for Subcutaneous Administration of it’s Anti-thrombotic Nanobody (ALX-0681)
Living in a sunny climate does not improve vitamin D levels in hip fracture patients
PolyOne Suzhou Achieves ISO 13485 Certification for Healthcare Quality Management
